Skip to main content
. 2018 Mar 7;18:22. doi: 10.1186/s12883-018-1030-7

Table 3.

Preprocedural Analysis

Parameter No Evidence of New/Enlarged ICH (n = 54) Evidence of New/Enlarged ICH (n = 27) p-value
Admission GCS, (Median ± IQR) a 10 ± 8.3 7 ± 9 0.1964
GCS (highest) 24 h prior to EVD, (Median ± IQR) a 11.5 ± 9 8 ± 7 0.2827
GCS (lowest) 24 h prior to EVD, (Median ± IQR) a 0.3437
INR (highest) from admission to EVD, (Median ± IQR) (n = 76) a 1.1 ± 0.2 1.1 ± 0.2 0.3437
aPTT (highest) from admission to EVD, (Median ± IQR) a 25.9 ± 4.5 27.3 ± 5.6 0.017
Preprocedural Anticoagulation, n (%) b 4 (7.4) 1 (3.7) 0.66
Preprocedural Antiplatelet,
n (%) b
2 (3.7) 1 (3.7) 1.0

aMann-Whitney U

bChi Square